Introduction
============

Granulomatosis with polyangiitis (GPA), formerly known as Wegener\'s granulomatosis, is a granulomatous disorder that most commonly presents with involvement of the sinuses, lungs, and kidneys. Cardiac involvement is uncommon, and is reported in \~8--44% of cases with Wegener\'s granulomatosis ([@b1-etm-0-0-4946]), which commonly manifested as pericarditis, myocarditis and arrhythmias. It can eventually lead to high blood pressure and heart failure. In addition, because GPA often causes small blood vessel lesions, there are only a small number of clinical reports of acute coronary syndrome caused by this disease ([@b2-etm-0-0-4946]--[@b5-etm-0-0-4946]).

In the clinical diagnosis of coronary heart disease, hypertension, diabetes and smoking are the most common risk factors for atherosclerosis. Effective treatments such as blood pressure control, hypoglycemic management and smoking cessation have been shown effectively to reduce the recurrence of cardiovascular disease. However, there are still \~15% coronary heart disease patients with unclear mechanism of atherosclerosis. This includes the large arterial inflammatory change caused by GPA. There is often not enough emphasis on this risk factor to delay the patient\'s diagnosis and treatment in clinical work.

In this study, we report a rare case that suffered angina involved in aortic atherosclerosis with GPA.

Case report
===========

We report a rare case of a 64-year-old man who was admitted to the hospital in April, 2015 with a 2-week history of chest discomfort, fever, headache, dizziness and bloody, purulent rhinorrhea. He denied a family history of cardiac disease and did not smoke. This study was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University. Signed written informed consents were obtained from the case. He had hypertension for 40 years, controlled with 150 mg irbesartan, 30 mg nifedipine, and 25 mg metoprolol. He also had diabetes mellitus for 6 years, and was taking glibenclamide 2 mg/day and acarbose 150 mg/day. He had a cerebral hemorrhage 15 years prior. Based on a history of dizziness and brain computed tomography (CT), he was diagnosed multiple times with acute cerebral infarction in the previous 13 years. Because of poor blood pressure control, he underwent a comprehensive physical examination one year previously. He was found to have diffuse atherosclerotic plaques involving the aorta, as well as carotid, iliac, renal and limb arteries. The right internal carotid artery, right external iliac artery, and left superficial femoral artery were occluded. The left renal artery had severe stenosis ([Fig. 1](#f1-etm-0-0-4946){ref-type="fig"}). After changing the antihypertensive drugs, the blood pressure remained well controlled. He had no discomfort, and took aspirin and atorvastatin as usual.

On admission, he complained of chest discomfort and fever. Blood pressure was 113/93 mmHg, heart rate was 64 beats/min; there were no respiratory or cardiac pathological findings on auscultation. We performed blood tests and CT scans ([Fig. 2](#f2-etm-0-0-4946){ref-type="fig"}). There were significant changes in the same parameters tested one year prior ([Table I](#tI-etm-0-0-4946){ref-type="table"}).

The patient underwent otolaryngologic evaluation for a bloody, purulent, bilateral nasal discharge. A biopsy of a right nasal sepal tumor showed a squamous epithelium with fibrous hyperplasia, many lymphocytes, plasma cells, neutrophil infiltration and leukemia-like vasculitis with local epithelial erosion. Based on the symptoms and examination results, rheumatology diagnosed granulomatous vasculitis. Because the patient had renal insufficiency and pneumonia, the family did not agree to coronary angiography. He then received glucocorticoids, cyclophosphamide, anti-inflammatory agents and coronary secondary prevention therapy. The fever and chest pain improved significantly. Pulmonary nodules also diminished.

Discussion
==========

The annual incidence of granulomatous vasculitis is \~0.4/100,000. It can present at any age, but is more common between the ages of 30--50 years. The male:female ratio is 1.6:1. The etiology has not been fully elucidated. It is easily misdiagnosed because the lesions are often limited to the upper respiratory tract in the early stage of disease. Approximately 6--44% of granulomatous vasculitis patients have comorbid pericarditis, myocarditis and coronary arteritis with cardiac involvement; of these, 50% have coronary artery vasculitis. In patients with atherosclerosis, GPA can accelerate the process, with a significant increase in morbidity and mortality due to cardiovascular disease, and a poor prognosis ([@b6-etm-0-0-4946]--[@b8-etm-0-0-4946]).

This patient had fever, upper respiratory tract symptoms, blood in the urine, multiple bilateral lung nodules, and renal lesions, and was positive for cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA). Histopathological examination of a sinus neoplasm indicated necrotizing vasculitis. The findings conformed to the 1990 American Rheumatism Association criteria for the diagnosis of granulomatous vasculitis. In addition, the patient\'s chest pain and electrocardiogram were diagnostic of angina pectoris. This middle-aged male patient had hypertension, diabetes, and other risk factors for atherosclerosis, and was found to have diffuse arterial plaques, partial occlusion and severe stenosis. These factors did not completely explain the coronary arterial lesions of GPA. However, the patient had incipient angina accompanied by GPA. This suggested the development of angina pectoris was associated with a rheumatologic disorder.

The patient had a history of hypertension for 40 years, and sustained kidney damage, recurrent cerebral infarctions, and vascular sclerosis and occlusion in recent years. However, no rheumatologic history was apparent; therefore, we could not conclude that the vascular lesions and true cause of high blood pressure were associated with the presence of vasculitis. Histopathological characteristics of coronary artery anatomy may ultimately provide answers.

At present, the main treatment of granulomatous vasculitis is glucocorticoid alone or in combination with an immune inhibitor. This treatment is highly effective for granulomatous vasculitis with damage to the lung, brain, and heart. However, the treatment of granulomatous vasculitis with angina pectoris, or myocardial infarction with coronary artery lesions, remains controversial ([@b9-etm-0-0-4946]--[@b11-etm-0-0-4946]). Because there is no strong evidence for the effectiveness of percutaneous coronary intervention in coronary artery stenosis caused by GPA, we chose to use glucocorticoids and immune inhibitors, combined with conservative treatment for coronary prevention, and achieved good early results.

Although granulomatous vasculitis is rare, it is also a risk factor for cardiovascular and cerebrovascular disease. Therefore, even if there are clear risk factors for atherosclerosis in patients with acute coronary syndrome, the presence of unexplained fever should prompt consideration of GPA. This will be of great significance for treatment and prognosis.

![Comprehensive physical examination in 2015. (A and B) CT angiography of the renal (yellow arrow), iliac (red arrow) and femoral arteries (blue arrow). (C) Carotid ultrasound. (D) Axillary artery ultrasound.](etm-14-04-3569-g00){#f1-etm-0-0-4946}

![The dynamic changes of the lung CT scan. (A) The lung CT in 2015. (B) The lung CT in 2016 without hormone therapy. Arrows indicate granulomatous nodules. (C) The lung CT in 2016 after hormone therapy.](etm-14-04-3569-g01){#f2-etm-0-0-4946}

###### 

Blood biochemistry inspection.

  Date      WBC (×10^9^/l)   HGB (g/l)      Cr (µmol/l)             CRP (µg/ml)   ESR (mm/h)
  --------- ---------------- -------------- ----------------------- ------------- -------------
  2015.02     9.58           157            117                       12            2
  2016.07   10.65            140            148                     148           35
  Date      C-ANCA           P-ANCA         Anti-PR3                IgG (g/l)     IgA (g/l)
  2015.02   −                \+             \+                      13.5          2.15
  2016.07   \+               −              \+                      23.7          4.04
  Date      C3 (g/l)         Urine RBC/HP   Proteinuria (mg/24 h)   EF (%)        cTNI (µg/l)
  2015.02   1.1              0.15           357.42                  56            0.06
  2016.07   0.8              42.6           1147.5                  58            0.01

HGB, hemoglobin; Cr, creatinine; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; EF, ejection fraction.
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